Phase 2 Study to Assess the Safety and Efficacy of ANG003

Clinical trial NCT07450547 · RECRUITING

Trial details

NCT number: NCT07450547
Sponsor: Anagram Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)

Start date: 2026-04-24
Primary completion: 2027-07-01
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.